May 15, 2026 07:30AM
Apr 10, 2026 08:39AM
Apr 10, 2026 08:31AM
Apr 10, 2026 08:30AM
Apr 10, 2026 08:30AM
Apr 8, 2026 09:15AM
Mar 19, 2026 07:31AM Annovis partners with NeuroRPM for AI biomarker platform in PD study
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 16, 2026 07:30AM
Feb 12, 2026 08:00AM
Feb 12, 2026 08:00AM Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease
Dec 18, 2025 04:35PM
Dec 18, 2025 04:35PM
Dec 18, 2025 04:35PM
Nov 18, 2025 08:45AM
Nov 18, 2025 08:00AM
Nov 18, 2025 08:00AM
Nov 18, 2025 08:00AM Annovis Announces FDA Meeting to Discuss Parkinson's Disease Dementia Program; Reaffirms FDA Alignment on Pivotal Phase 3 Alzheimer's Disease Study
Nov 18, 2025 08:00AM
Sep 30, 2025 07:05AM
Aug 7, 2025 08:00AM
Aug 7, 2025 08:00AM
Jun 5, 2025 08:00AM
Jun 5, 2025 08:00AM
Mar 21, 2025 05:05PM Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Feb 5, 2025 08:01AM
Feb 5, 2025 08:00AM
Jan 7, 2025 08:01AM
Jan 7, 2025 08:00AM
Jan 7, 2025 08:00AM
Jan 7, 2025 08:00AM
Nov 25, 2024 08:00AM Annovis to Host Year-End Investor Webcast on December 11, 2024
Nov 11, 2024 08:00AM
Oct 31, 2024 08:00AM
Oct 16, 2024 06:56AM
Oct 15, 2024 08:03AM
Oct 15, 2024 08:00AM
Oct 2, 2024 08:30AM
Sep 30, 2024 08:05AM Annovis Bio Inc. (ANVS) Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra
Sep 30, 2024 08:00AM
Sep 3, 2024 07:22AM
Aug 15, 2024 07:00AM
Aug 6, 2024 09:00AM
Aug 6, 2024 08:30AM
Jul 16, 2024 08:01AM
Jul 16, 2024 08:00AM Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap
Jul 9, 2024 08:00AM

323,580 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All